Silo Pharma, Inc. (SILO)

Silo Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.28	4.75	3.91	3.52	11.37	9.84
Short-Term Investments	1.95	2.11	3.17	4.14	0	0.42
Cash & Short-Term Investments	5.23	6.86	7.08	7.67	11.37	10.26
Cash Growth	-16.50%	-3.13%	-7.63%	-32.58%	10.85%	808.83%
Accounts Receivable	-	0	0	0	0	0
Receivables	-	0	0	0	0.07	0
Prepaid Expenses	0.28	0.19	0.03	0.01	0.12	0.06
Other Current Assets	0.21	0.34	0.01	0.01	0.02	0.08
Total Current Assets	5.71	7.39	7.11	7.68	11.57	10.4
Other Intangible Assets	0.21	0.22	0.24	-	-	-
Long-Term Accounts Receivable	-	-	0.01	0.01	0.01	0.01
Long-Term Deferred Charges	0.03	-	0.05	0.06	0.06	0.02
Total Assets	5.95	7.61	7.41	7.75	11.64	10.49

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.36	0.58	1.58	0.7	0.22	0.42
Accrued Expenses	-	-	-	-	0.14	-
Current Unearned Revenue	-	0.07	0.07	0.07	0.07	0.07
Total Current Liabilities	1.07	0.65	1.66	0.78	0.44	0.49
Long-Term Unearned Revenue	-	0.65	0.72	0.79	0.87	0.94
Total Liabilities	1.07	1.3	2.38	1.57	1.3	1.43

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	26.85	25.79	20.3	17.53	17.51	12.32
Retained Earnings	-21.97	-19.49	-15.26	-10.87	-7.17	-3.26
Treasury Stock	-	-	-	-0.47	-	-
Comprehensive Income & Other	0.01	0.01	0	-0.01	-	-
Total Common Equity	4.89	6.31	5.03	6.18	10.34	9.06
Shareholders' Equity	4.89	6.31	5.03	6.18	10.34	9.06
Total Liabilities & Equity	5.95	7.61	7.41	7.75	11.64	10.49

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	5.23	6.86	7.08	7.67	11.37	10.26
Net Cash Growth	-16.50%	-3.13%	-7.63%	-32.58%	10.85%	824.31%
Net Cash Per Share	5.92	12.27	28.86	37.33	74.66	80.20
Filing Date Shares Outstanding	1.59	0.94	0.3	0.19	0.21	0.13
Total Common Shares Outstanding	1.13	0.89	0.3	0.19	0.21	0.13
Working Capital	4.65	6.74	5.46	6.91	11.14	9.91
Book Value Per Share	4.33	7.10	16.84	31.88	49.10	68.91
Tangible Book Value	4.67	6.09	4.79	6.18	10.34	9.06
Tangible Book Value Per Share	4.14	6.86	16.03	31.88	49.10	68.91

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error